Scaffold Hopping from Quinazoline to Tetrahydropyrido[3,4- d ]pyrimidine: Enhancing the Potency and Selectivity of HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors

In this work, a series of tetrahydropyrido[3,4-d]pyrimidine derivatives were rationally designed as HIV-1 non-nucleoside reverse transcriptase inhibitors via scaffold modification. Most compounds demonstrated promising potency against wild-type HIV-1 (IIIB) and clinically relevant mutants. Notably, 10p showed the strongest activity against HIV-1 IIIB, L100I, K103N, Y188C, Y188L, and E138K (EC50 = 2.4−16.5 nM). Importantly, 10p maintained potent efficacy against F227L/V106A (EC50 = 12.3 nM) and K103N/Y181C (EC50 = 21.7 nM). In vitro assessment revealed that the metabolic clearance rate of 10p in human liver microsomes was moderately lower than that of rilpivirine. Additionally, 10p showed a low potential for CYP-mediated drug interactions and had a negligible inhibitory effect on the hERG potassium channel. In the acute oral toxicity study in mice, no adverse effects were observed at a dose of up to 2000 mg/kg. These findings identify 10p as a promising lead compound for further development.

Authors

Institutions

Publication Details

Journal
Journal of Medicinal Chemistry
Published
2026-11-18
DOI
https://doi.org/10.1021/acs.jmedchem.6c02971
Primary Topic
HIV/AIDS drug development and treatment
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Scaffold Hopping from Quinazoline to Tetrahydropyrido[3,4- d ]pyrimidine: Enhancing the Potency and Selectivity of HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors

Limin Zhao, Phuong‐Thao Tran, Christophe C. Pannecouque, Fen‐Er Chen et al.
3 links
Journal of Medicinal Chemistry
HIV/AIDS drug development and treatment
article

Scaffold Hopping from Quinazoline to Tetrahydropyrido[3,4- d ]pyrimidine: Enhancing the Potency and Selectivity of HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors

Limin Zhao, Phuong‐Thao Tran, Christophe C. Pannecouque, Fen‐Er Chen, Erik De Clercq, Li Qiang Wan, Shuai Wang, Yujie Zhang, Xiaomei Chen, Peng Qi, Lingbo Qu, Ling Dong, Zhen-Zhu Lei, Yu-Ting Niu, Hao Deng, Qian Xu, Xian-Kai Li, Peng Liu
article en

Abstract

In this work, a series of tetrahydropyrido[3,4-d]pyrimidine derivatives were rationally designed as HIV-1 non-nucleoside reverse transcriptase inhibitors via scaffold modification. Most compounds demonstrated promising potency against wild-type HIV-1 (IIIB) and clinically relevant mutants. Notably, 10p showed the strongest activity against HIV-1 IIIB, L100I, K103N, Y188C, Y188L, and E138K (EC50 = 2.4−16.5 nM). Importantly, 10p maintained potent efficacy against F227L/V106A (EC50 = 12.3 nM) and K103N/Y181C (EC50 = 21.7 nM). In vitro assessment revealed that the metabolic clearance rate of 10p in human liver microsomes was moderately lower than that of rilpivirine. Additionally, 10p showed a low potential for CYP-mediated drug interactions and had a negligible inhibitory effect on the hERG potassium channel. In the acute oral toxicity study in mice, no adverse effects were observed at a dose of up to 2000 mg/kg. These findings identify 10p as a promising lead compound for further development.

Journal of Medicinal Chemistry
Fudan University (CN), Zhengzhou University (CN), Henan Academy of Sciences (CN), Hanoi University of Pharmacy (VN), Jiangxi Normal University (CN), KU Leuven (BE)
National Natural Science Foundation of China, Fudan University, National Key Research and Development Program of China
Good health and well-being
HIV/AIDS drug development and treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon